Editorial: increasing IBD prevalence and its complications in the context of the COVID‐19 pandemic. Authors' reply

Abstract

Study of Inflammatory Bowel Disease (IOIBD) has undertaken a RAND panel of expert opinion regarding the care of IBD patients during the In time the evidence to support clinical recommendations is likely to develop. Others from epicentres of the COVID-19 pandemic have also given specific recommendations based on their experience. 10The paper by King et al reminds us of two important and interacting challenges facing IBD clinicians in the future. First, we will continue to see more IBD as the prevalence increases worldwide. This will require improved management strategies to provide high-quality care to more patients. Second, complications of the disease and its treatment, be they established or evolving will require individualised approaches.While some planning will be needed to mitigate these, working together at times of crisis will enable the best results for our patients. ACK N OWLED G EM ENTSDeclaration of personal interests: Richard Gearry has served as a speaker, a consultant and an advisory board member for AbbVie and Zespri International, and has received research funding from Zespri International.

SARS-CoV-2 microbiome dysbiosis linked disorders and possible probiotics role

“…Only 44 % of them have been to a clinic in the past three years. During the current coronavirus pandemic, an increased incidence of IBD has been documented [ 76 ]. As anxiety in IBD patients is more common because of social distancing and isolation in COVID-19 as described previously [ 77 ], it may worsen patients' condition, which might not be underestimated.…”

COVID‐19 and inflammatory bowel disease crosstalk: From emerging association to clinical proposal

“…It has been found that the incidence rate of IBD increased during the outbreak of COVID‐19. 41 SARS‐CoV‐2 can enter human cells through the recognition of ACE2 receptor, which is also highly expressed in the intestine. 42 , 43 Generally speaking, virus infection can damage the intestinal mucosa, destroy the digestion and absorption function of the intestine, affect the absorption of water by the intestine, and lead to enteritis.…”

“…It has been found that the incidence rate of IBD increased during the outbreak of COVID‐19 41 . SARS‐CoV‐2 can enter human cells through the recognition of ACE2 receptor, which is also highly expressed in the intestine 42,43 .…”